You searched for "treatment"
Sinclair presents Sculpt&Shape® at IMCAS Paris 2023
Sinclair, formally Sinclair Pharma (“Sinclair”, www.sinclair.com) a global aesthetics company headquartered in London and fully owned subsidiary of Huadong Medicine Corporation Limited presents Sculpt&Shape® at the IMCAS 2023 congress in Paris.Can 3D facial imaging improve patient management in disfiguring eye disease?
Fight for Sight is the leading UK charity funder of eye research. Since the 2013 Sight Loss and Vision Priority Setting Partnership we have encouraged our researchers to work on priorities jointly identified by people affected by sight loss and...Recent developments in hyaluronic acid research
Hyaluronic acid has a role in many medical specialties, not just aesthetics. Anna Baker takes us through the latest evidence and therapeutic indications. The evidence and demand for hyaluronic acid (HA) based technologies continues to expand and evolve across a...Body dysmorphia disorder in the cosmetic clinic: a novel encrypted screening approach
In the following article and case study, the condition of body dysmorphia disorder (BDD) is examined in the context of its pathogenesis and the role of the cosmetic practitioner. BDD is a problem that affects patients on a deeply personal...
Platysma muscle use for oral sphincter substitution or countering excessive pull of a free muscle, following facial palsy
The use of the platysma muscle as a pedicled ‘apron’ flap in order to minimise the overactivity of a free muscle transfer, used in the treatment of facial palsy, is described in admirable detail. The successful results are carefully assessed...How I Do It - Treating melasma and PIH
Melasma and post-inflammatory hyperpigmentation (PIH) are among the most common skin disorders in society with prevalence of up to 50% in some populations. Melasma is more prevalent among females and also among those with darker skin types III–V on the...
